Accenture ACN Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $11.48B+129% | $5B-44.7% | $9.05B+14.6% | $7.89B-3.4% | ||
| $5.95M+10.2% | $5.4M+17.9% | $4.58M+15.2% | $3.97M-7.5% | ||
| —— | —— | -$87.67M-103% | $2.59B+76.3% | ||
| $28.9B+38.6% | $20.86B-10.8% | $23.38B+8.2% | $21.61B+9.9% | ||
| $1.57B+3.0% | $1.52B-0.6% | $1.53B-7.8% | $1.66B+1.2% | ||
| $22.54B+6.7% | $21.12B+35.6% | $15.57B+18.6% | $13.13B+18.0% | ||
| $2.41B-17.0% | $2.9B+40.1% | $2.07B— | —— | ||
| $36.49B+4.0% | $35.07B+25.9% | $27.86B+8.6% | $25.65B+9.1% | ||
| $65.39B+16.9% | $55.93B+9.1% | $51.25B+8.4% | $47.26B+9.5% | ||
| $2.7B-1.8% | $2.74B+10.1% | $2.49B-2.7% | $2.56B+12.6% | ||
| $642.36M+0.2% | $641.09M-2.0% | $653.95M-8.2% | $712.72M+1.8% | ||
| $114.48M-87.9% | $946.23M+803% | $104.81M+1,042% | $9.18M-24.0% | ||
| $20.35B+7.3% | $18.98B+5.4% | $18.01B+2.8% | $17.52B+11.6% | ||
| $5.03B+6,303% | $78.63M+82.5% | $43.09M-6.1% | $45.89M-14.2% | ||
| $12.8B+64.4% | $7.79B+14.9% | $6.78B-3.1% | $6.99B-5.1% | ||
| $21.02B-8.9% | $23.08B+19.5% | $19.32B+6.1% | $18.2B+30.1% | ||
| $31.2B+10.3% | $28.29B+10.1% | $25.69B+16.2% | $22.11B+13.2% | ||
| $65.39B+16.9% | $55.93B+9.1% | $51.25B+8.4% | $47.26B+9.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Accenture's total assets?
- Accenture (ACN) holds $68.8B in total assets, up 8.6% year over year.
- How much debt does Accenture have?
- Accenture carries $8.4B in total debt against $31.9B of shareholders' equity, a debt-to-equity ratio of 0.26.
- How much cash does Accenture have?
- Accenture holds $10.2B in cash and equivalents.
- Can Accenture cover its short-term obligations?
- Its current ratio is 1.34 — current assets exceed current liabilities.
- Where does Accenture's balance sheet data come from?
- Every line is extracted from Accenture's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
